Biggest News Aggregation in the World
📰 Interim Head News

Page 30 - Interim Head News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Interim Head. Real-time updates on events, politics, business and more.

Biogen Inc.: Biogen and Alectos Therapeutics Announce License and Collaboration Agreement for AL01811, a Novel GBA2 Inhibitor for the Potential Treatment of Parkinson's Disease

AL01811 is a preclinical selective GBA2 inhibitor with first-in-class potential as an oral disease modifying treatment for Parkinson's DiseaseAlectos to receive a $15 million upfront payment and is eligible
United Kingdom Walter Gilbert Charles Weissmann Heinz Schaller Ernest Mceachern Ashleigh Koss

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science